NUWE Stock Analysis: Buy, Sell, or Hold?
NUWE - Nuwellis, Inc. Common Stock
$3.77
-0.42 (-10.02%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 10, 2026
Get Alerted When NUWE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
21 traders called NUWE this week
78% bullish • 6 bearish
78% bullish • 6 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: NUWE is 35.1% above fair value ($2.79). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: NUWE is 35.1% above fair value ($2.79). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: NUWE is currently trading at $3.77, which is considered extended relative to its 30-day fair value range of $1.61 to $2.79.
Technical Outlook: Technically, NUWE is in a strong downtrend. Immediate support is located at $1.72, while resistance sits at $4.94. Short-term momentum is weak, with the stock down 10.0% recently.
Market Sentiment: NUWE has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.00 (+162.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NUWE is in a strong downtrend. Immediate support is located at $1.72, while resistance sits at $4.94. Short-term momentum is weak, with the stock down 10.0% recently.
Market Sentiment: NUWE has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.00 (+162.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$1.61 -
$2.79
Company Quality Score
62/100
(BUY)
Volume Confirmation
MODERATE
Confidence Score
42.1%
Protect Your Profits
Holding NUWE? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+35.1% above fair value)
- BULLISH: Strong technical setup (75/100)
- BEARISH: Downward momentum (-10.0%)
- BULLISH: Trading 162.5% below Wall St target ($11.00)
Fair Price Analysis
30-Day Fair Range
$1.61 -
$2.79
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$1.72
Resistance Level
$4.94
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-2.24
Wall Street Target
$11.00
(+162.5%)
Revenue Growth (YoY)
-6.3%
Earnings Growth (YoY)
-99.2%
Profit Margin
-202.8%
Last updated: January 31, 2026 3:18 PM ET
Data refreshes hourly during market hours. Next update: 4:18 PM
Data refreshes hourly during market hours. Next update: 4:18 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NUWE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$427 | 68 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$110 | 63 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$374 | 54 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 59 HOLD |
Advanced NUWE Option Strategies
Professional options setups generated by AI based on today's NUWE price and gamma walls.
